Variant report
Variant | esv20179 |
---|---|
Chromosome Location | chr7:55808883-55812203 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546747298 | chr7:55808897-55808898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs578210453 | chr7:55808898-55808899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545247458 | chr7:55808928-55808929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557536224 | chr7:55808935-55808936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs199970097 | chr7:55808943-55808944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs61187951 | chr7:55808945-55808946 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs149380718 | chr7:55808969-55808970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190590121 | chr7:55808974-55808975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375366764 | chr7:55808976-55808977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528446150 | chr7:55809006-55809007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs557418671 | chr7:55809035-55809036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554225898 | chr7:55809039-55809040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540658173 | chr7:55809110-55809111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12671710 | chr7:55809125-55809126 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs533259933 | chr7:55809131-55809132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551245369 | chr7:55809143-55809144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533735325 | chr7:55809159-55809160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530771360 | chr7:55809160-55809161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28609828 | chr7:55809174-55809175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549076476 | chr7:55809203-55809204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567400228 | chr7:55809216-55809217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534563444 | chr7:55809221-55809222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546600062 | chr7:55809225-55809226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571803996 | chr7:55809227-55809228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539330833 | chr7:55809228-55809229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557410876 | chr7:55809283-55809284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372064363 | chr7:55809292-55809293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377007884 | chr7:55809304-55809305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139599002 | chr7:55809314-55809315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374302850 | chr7:55809317-55809318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536477990 | chr7:55809319-55809320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377220283 | chr7:55809320-55809321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554629522 | chr7:55809330-55809331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573021650 | chr7:55809336-55809337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540215130 | chr7:55809337-55809338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs369084321 | chr7:55809380-55809381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10273914 | chr7:55809399-55809400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565291045 | chr7:55809430-55809431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373003900 | chr7:55809468-55809469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573813764 | chr7:55809477-55809478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577208174 | chr7:55809479-55809480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75458298 | chr7:55809482-55809483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545282838 | chr7:55809511-55809512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563599876 | chr7:55809520-55809521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79059565 | chr7:55809523-55809524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79187880 | chr7:55809525-55809526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530707185 | chr7:55809529-55809530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181395301 | chr7:55809554-55809555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560940248 | chr7:55809570-55809571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528194655 | chr7:55809580-55809581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal cancer | 21851588 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung cancer | 21911935 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17925434 | CNVD |
Glioma | 24330732 | CNVD |
Lung adenocarcinoma | 23938291 | CNVD |
Glioma | 17634744 | CNVD |
Oral squamous cell carcinoma | 19276369 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Lung cancer | 20031968 | CNVD |
Glioblastoma | 17090523 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Glioma | 17123091 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Breast cancer | 17142309 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:55806800-55814800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr7:55809400-55809600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr7:55809600-55810200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr7:55810200-55811000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr7:55811000-55811200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr7:55811000-55811200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |